[Studies on monoamine oxidase inhibitors. VII. Derivatives of quinolinecarboxylic acids]. 1966

J Piechaczek, and H Bojarska-Dahlig

UI MeSH Term Description Entries
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D011804 Quinolines
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal

Related Publications

J Piechaczek, and H Bojarska-Dahlig
January 1963, Acta poloniae pharmaceutica,
J Piechaczek, and H Bojarska-Dahlig
January 1962, Acta poloniae pharmaceutica,
J Piechaczek, and H Bojarska-Dahlig
June 1966, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
J Piechaczek, and H Bojarska-Dahlig
January 1964, Acta poloniae pharmaceutica,
J Piechaczek, and H Bojarska-Dahlig
January 1964, Acta poloniae pharmaceutica,
J Piechaczek, and H Bojarska-Dahlig
May 1964, Journal of medicinal chemistry,
J Piechaczek, and H Bojarska-Dahlig
January 1961, Le Progres medical,
J Piechaczek, and H Bojarska-Dahlig
January 1963, Acta poloniae pharmaceutica,
J Piechaczek, and H Bojarska-Dahlig
January 1966, Acta biologica et medica Germanica,
J Piechaczek, and H Bojarska-Dahlig
January 2019, Frontiers in pharmacology,
Copied contents to your clipboard!